Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Lupin Pharmaceuticals, Inc

Lupin is one of the world's largest manufacturers of drugs that combat tuberculosis,bacterial infections,and cardiovascular disease.Our portfolio of drugs, manufactured in global-scale USFDA and UKMCA approved plants,also includes NSAIDS,Cox2 inhibitors and herbal-based phytomedicines.


Contact Details:
Harborplace Tower111 South Calvert Street 21st floor
Baltimore
Maryland
21202
United States of America
Tel:1-410 576 2000
Fax:1-410 576 2221
Email:ussales@lupinworld.com
WWW:

www.lupinworld.com/




Loading...

Press Releases on Lupin Pharmaceuticals, Inc:

BioPortfolio Logo
Lupin Expands Branded Play 30th June, 2009 Lupin Ltd.
Announces Acquisition of Worldwide Rights for its first NDA - AllerNaze(TM) BSE: 500257 NSE: Lupin REUTERS: LUPN.BO BLOOMBERG: LPC IN MUMBAI, India, June 30 /PRNewswire/ -- Pharmaceutical Major,
Greater Baltimore Committee to Announce Winners of 2009 Maryland Bioscience Awards at Ceremonies on March 12 10th March, 2009 Greater Baltimore Committee
BALTIMORE, March 10 /PRNewswire-USNewswire/ -- The following release is being issued by the Greater Baltimore Committee: WHO: Donald C. Fry, president & CEO, Greater Baltimore Committee 150
Lupin is Granted USFDA Approval for Levetiracetam Tablets 16th January, 2009 Lupin Pharmaceuticals, Inc.
BALTIMORE, Jan. 16 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval for the Company's Abbreviated New Drug Application (ANDA) for
Lupin Receives USFDA Approval for Divalproex Sodium Delayed-Release Tablets 31st July, 2008 Lupin Pharmaceuticals, Inc.
BALTIMORE, July 31 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval for the Company's Abbreviated New Drug Application (ANDA) for

BioNews Results for Lupin Pharmaceuticals, Inc:

Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA
Genetic Engineering News:  Nov 10 2009 3:18PM Matching: lupin pharmaceuticals inc
Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA
Pharmacy Choice:  Nov 10 2009 10:59PM Matching: lupin pharmaceuticals inc
Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA
Yahoo! Canada:  Nov 10 2009 8:28PM Matching: lupin pharmaceuticals inc
Sun Pharma loses patent battle against Forest Labs on Alzheimer's drug
PharmaBiz:  Oct 23 2009 3:14AM Matching: lupin pharmaceuticals inc

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1573 times since April 2007, the link to the organisation's website has been followed 146 times

Recent Search Terms used to find this page: profile of lupin pharma | lupin pharmaceuticals | Company profile of Lupin pharmaceuticals | lupin pharmaceuticals | lupin pharmaceuticals logo download | new ceo of lupin | lupin pharma india | lupin pharma | lupin pharma | lupin pharma india | .

Search for more companies in Baltimore

Search for more companies in Maryland



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Lupin Pharmaceuticals, Inc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.